Skip to content
Review

Navigating the cGAS-STING signaling pathway in breast cancer: Reinterpreting the paradox of antitumor and pro-metastatic.

Jul 2026 · Critical reviews in oncology/hematology · Vol 225, pp. 105487 · 0 citations · 54 references
Medicine

TL;DR

A conceptual framework of "cGAS-STING pathway-guided signal flow" is proposed, which clarifies signal branching mechanisms between the IFN-I antitumor axis and the NF-κB metastasis-promoting axis in breast cancer, identifies key nodes in signal branching, and evaluates the STING regulatory characteristics of various molecular subtypes.

Abstract

The cGAS-STING signaling pathway exhibits functions in breast cancer that include both antitumor immunity and pro-metastatic inflammation, transcending traditional linear switch models. To address this cognitive bottleneck, this paper proposes the conceptual framework of "cGAS-STING pathway-guided signal flow." It attributes pathway outcomes to multi-level fine-tuning, aiming to decipher initial immunogenic/pathogenic signals in the upstream phase based on intensity, duration, and origin. It elucidates how the STING protein, as a central hub, integrates and programs signals through a complex network of post-translational modifications at the midstream, thereby determining whether downstream effector branching favors the IFN-I-mediated antitumor axis or the NF-κB-driven pro-metastatic inflammatory axis. Based on this framework, this paper examines the key checkpoints at each level to explore in depth how to precisely regulate the cGAS-STING signaling pathway in order to maximize antitumor immune responses while mitigating potential risks of metastasis. This navigational framework clarifies signal branching mechanisms between the IFN-I antitumor axis and the NF-κB metastasis-promoting axis in breast cancer, identifies key nodes in signal branching, and evaluates the STING regulatory characteristics of various molecular subtypes. This provides both theoretical and practical foundations for signal reprogramming interventions, patient stratification, and the optimization of combination therapies.

View source

Similar papers

Review Open access Sep 2026

Context-Dependent cGAS-STING Activation Shapes Metastatic Progression and Dormancy

Mechanisms linking genome instability and cytoplasmic DNA to STING activation are reviewed, evidence for tumor-suppressive versus tumor-promoting functions across metastatic niches is summarized, and how STING agonists and combination strategies may be optimized to maximize antitumor immunity while avoiding protumorige...

Eilma Akter-Yasuoka, Tak C. Lee, Takahiko Murayama et al. · 0 citations
Review Open access Aug 2026

cGAS–STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy

A detailed understanding of the cGAS-STING axis has substantial value in providing theoretical guidance and supporting clinical translation in the development of next-generation combination immunotherapies, as well as broadening the patient population benefiting from clinical interventions.

Xin-Ru Zhao, Shuai Meng, Hanzeng Cheng et al. · 0 citations
Review Open access Oct 2026

The cGAS-STING pathway in ovarian cancer: from genomic instability to immunotherapeutic vulnerability

Ovarian cancer remains the most lethal gynecologic malignancy, a status largely attributable to late-stage diagnosis and inevitable chemoresistance. The cGAS-STING pathway, a cornerstone of innate immune surveillance, has emerged as a critical nexus linking genomic instability to antitumor immunity—a connection of part...

Hui-Hui Chen, Feng-Xian Ni, Dong-Hui Huang et al. · 0 citations
Review Open access Sep 2026

Context-dependent roles of cGAS-STING signaling in glioblastoma: Therapeutic resistance, drug delivery, and heterogeneity-informed translation.

A heterogeneity-informed framework for patient stratification and precision immunotherapy development in GBM is proposed, and major translational challenges are highlighted, including blood-brain barrier penetration, cell-type-specific pathway activation, treatment-induced pathway remodeling, and biomarker selection.

Yu-Zhu Long, Tong-Cui Jiang, Yu Long et al. · 0 citations
Review Aug 2026

THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response

Thrombospondin-2 has emerged as a pivotal yet paradoxical regulator within the breast cancer tumor microenvironment and is a key architect of an immunosuppressive “cold” TME, so therapeutic inhibition of THBS2 presents a promising integrative “cold-to-hot” conversion strategy.

Xi Wan, Xin-Chen Zhao, Yao Lin et al. · 0 citations
Review Sep 2026

The cGAS-STING pathway: mechanistic basis, dual biological functions and translational therapeutic advances

This review systematically investigates the distinct functional states and biological behaviors of the cGAS-STING pathway under a variety of disease conditions to provide comprehensive theoretical references and research directions for follow-up basic mechanistic studies and clinical transformation of cGAS-STING target...

Minjue Shan, Yan Liao, Zi-You Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.